Provided by Tiger Fintech (Singapore) Pte. Ltd.

Can Fite Biofarma

1.05
-0.0400-3.67%
Volume:219.59K
Turnover:229.34K
Market Cap:13.50M
PE:-0.97
High:1.09
Open:1.09
Low:1.03
Close:1.09
Loading ...
Mar 25, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 30, 2020

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 07, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 27, 2020

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jul 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 10, 2020

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Jun 19, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 19, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 01, 2020

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 13, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 07, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 02, 2020

Report of foreign issuer

6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 01, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 30, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 27, 2020

Public Prospectus

F-1 - Registration statement for certain foreign private issuers